PRIME includes over a dozen innovative metrics that assess project objectives while progressing the national performance measurement landscape. As part of the planned PRIME Innovative Metric Testing and Revision process, DHCS, SNI and DHLF are providing PRIME entities multiple opportunities for feedback on iterative drafts culminating in a final draft for the DY15 Manual.
In addition to your feedback via Surveymonkey, stewards will make revisions based on analysis of the DY13 Year End data, NCQA’s recommended modifications, and PCS inquiries from PRIME Entities.
PLEASE NOTE: For DY14 Mid-Year reporting in March, you must use the DY14 Manual released January 11, 2019. Do NOT use Innovative Metric Revision #1 or #2 Drafts for DY14 Mid-Year Reporting.
Timeline (Dates are subject to change)
Rolling Revision #2 posted on Surveymonkey
2 wks from posting Deadline for PRIME Entity feedback on Revision #2 via Surveymonkey
June 4-7 Call with Measure Stewards and Entities if needed.
End of June Final draft (Revision #3) published in DY15 Year End Manual
Survey is now closed.
PRIME Managers: Please disseminate this information to the appropriate project leads, managers, and clinicians at your system.
PRIME Entities have the opportunity to discuss any outstanding issues with the innovative metric stewards on a webinar call before the specification is finalized for the PRIME DY15 Year End Manual. Click on the links below to register and receive a calendar invite.
If no feedback is received via the Surveymonkey on Revision #2 by the deadline, the call will be canceled. Cancellation will be made known on this webpage soon after the Revision #2 feedback deadline.
If you have any questions, please contact your DHCS PRIME Liaison.
|PRIME Innovative Metric:||Revision#2 Draft for Round 2 Feedback:||Round 2 Feedback Deadline||Call with Innovative Metric Stewards + PRIME Entities|
|1.2.11 REAL Data Completeness||No recommended changes at this time. Please provide feedback on the spec version in the DY14 Manual||Tues, 5/28|
|1.2.13 SO/GI Data Completeness|
|1.3.5 Referral Reply Turnaround Rate||Link to Revision #2 Draft||Mon, 6/3||Project 1.3
Tues, 6/4 4-5PM
|1.3.6 Specialty Care Touches|
|1.4.1 Abnormal Results Follow-Up||Link to Revision #2 Draft||Tues, 5/28||6/7 call canceled as is no longer needed|
|1.4.3 INR Monitoring for Individuals on Warfarin||No recommended changes at this time. Please provide feedback on the spec version in the DY14 Manual||Tues, 5/28|
|1.6.1 BIRADS to Biopsy||No recommended changes at this time. Please provide feedback on the spec version in the DY14 Manual||Tues, 5/28|
|1.6.5 Receipt of Appropriate FU for abnormal CRC Screening|
|2.4.8 Comprehensive Medical Evaluation Following Foster Youth Placement in Foster Care||No recommended changes at this time. Please provide feedback on the spec version in the DY14 Manual||Tues, 5/28|
|2.6.2 Assessment and Management of Chronic Pain||Link to Revision #2 Draft||Tues, 5/28||Project 2.6
Fri, 6/7 3-4PM
|2.6.3 Patients w/Chronic Pain on Long Term Opioid Therapy Checked in PDMPs|
|2.6.5 Treatment of Chronic Non-Malignant Pain w/ Multi-Modal Therapy|
|2.7.4 MWM #8: Treatment Preferences Outpatient||Link to 2.7.4 Revision #2 Draft||Tues, 5/28||Project 2.7.5
Tues, 6/4 1-2PM
|2.7.5 Palliative Care Services Offered at Time of Diagnosis of Advanced Illness||Link to 2.7.5 Revision #1 Draft||Tues, 5/28|
|3.1.3 Variation on NHSN Antimicrobial Use Measure||Link to Revision #2 Draft||Tues, 5/28||6/5 call canceled as is no longer needed|
|3.1.4 Peri-op Prophylactics Antibiotics Not Administered After Surgical Closure|
|3.2.4 Use of Imaging for Low Back Pain (red flags, no time limit)||Link to Revision #2 Draft||Wed, 6/5||Project 3.2.4
Thurs, 6/6 12-1PM
|3.3.1 Adherence to Medications||Link to Revision #2 Draft||Fri, 5/31||6/8 call canceled as is no longer needed|
|3.3.3 High Cost Pharmaceuticals Ordering Protocols|
|3.3.4 Documentation of Medication Rec in the Medical Record||No recommended changes at this time. Please provide feedback on the spec version in the DY14 Manual||Tues, 5/28|